Summaries of the Fujifilm Group's extensive CSR activities and results.
Dear InnovationOur thoughts on Innovation
Proprietary technology for early diagnosis
The new leader in the AMULET series. Tomosynthesis, 3D Mammography and biopsy are all available.
High quality images for easier diagnosis with greater comfort for patients and usability for radiographers.
Patented direct conversion flat panel detector technology for 50-micrometer imaging precision.
The high-throughput FCR reader capable of precise 50µm resolution for mammography with a dual-side reading.
High-resolution one-stacker FCR reader capable of 50µm resolution for mammography with a double-side reading.
FCR CAPSULA XLII equipped with the optional capability of 50-micron reading with the HR-V can visualize more fine and minute structures. It is suited for mammography applications.
A simple reader unit but with proven image quality and product durability.
For all women. Finer viewing detail and enhanced ease of use. Optimized workflow and imagingMammo console for PROFECT.
Computer aided detection (CAD) system analyzes images to help detect breast cancer.
A dedicated quality control program for Fujifilm digital mammography systems to support stable image quality in screening and diagnosis.
Stereotactic biopsy examination with high resolution -50µm pixel pitch.
Smart mammography workstation for streamlined workfklow and precise diagnosis
Innovative mammography system which relalizes more precise diagnosis with 3D images.
Read more about our products in these downloadable PDF format brochures.
If you have any questions about products or services, please contact us.
About Fujifilm's advanced image processing technology.
Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation.